메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한폐경학회 대한폐경학회지 대한폐경학회지 제23권 제1호
발행연도
2017.1
수록면
56 - 62 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objectives: To evaluate and compare the efficacy and safety of the combination of raloxifene and alendronate with those ofmonotherapies in elderly women with osteoporosis. Methods: Sixty-two postmenopausal women (mean age 63.5 ± 0.5 years) attending gynecologic osteoporosis clinics withestablished osteoporosis were randomly allocated to one of four treatment groups and monitored for 3 years. All patients enrolledin this study, including those in the control group (n = 14), received 1.0 g elemental calcium and 400 units of vitamin D per day. The raloxifene group (n = 16) received raloxifene 60 mg (Evista®) per day; alendronate group (n = 17) received low-dose (5 mg)alendronate with calcitriol 0.5 μg (Maxmarvil®) per day; and the combination therapy group (n = 15) received both raloxifene 60mg and low-dose (5 mg) alendronate with calcitriol 0.5 μg. Bone mineral density (BMD) was measured in the lumbar spine and hipbefore and after 3 years of treatment. Results: In patients who received the combined therapy, BMD increased in the lumbar spine and the hip by 7.2% (P < 0.001)and 4.8% (P < 0.001) at 3 years. For patients in the alendronate group, the increases were 6.7% (P < 0.001) and 3.1% (P < 0.01)respectively, for the raloxifene group, the increases were 4.36% (P < 0.001) and 1.9% (P < 0.05) in the vertebrae and femora,respectively; however, the BMD of patients in the control group decreased by 1.81% (P < 0.05) and 1.6% (P < 0.05), respectively,after 3 years. Patients who received the combination therapy had significantly higher BMD in both the vertebrae femora (P < 0.01)in comparison to that in those treated with raloxifene or alendronate individually. Conclusions: This 3-year randomized study showed the improved effects of alendronate and raloxifene combination on spine andhip BMD in elderly postmenopausal women with established osteoporosis. (J Menopausal Med 2017;23:56-62)

목차

등록된 정보가 없습니다.

참고문헌 (23)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0